235 related articles for article (PubMed ID: 26050385)
1. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
Idoko J; Folayan MO
Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
[TBL] [Abstract][Full Text] [Related]
2. "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.
Idoko J; Folayan MO; Dadem NY; Kolawole GO; Anenih J; Alhassan E
BMC Public Health; 2015 Apr; 15():349. PubMed ID: 25881087
[TBL] [Abstract][Full Text] [Related]
3. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
[TBL] [Abstract][Full Text] [Related]
4. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
Supervie V
Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
[TBL] [Abstract][Full Text] [Related]
5. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
[TBL] [Abstract][Full Text] [Related]
6. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
[TBL] [Abstract][Full Text] [Related]
7. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
Heffron R; Ngure K; Mugo N; Celum C; Kurth A; Curran K; Baeten JM
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):116-9. PubMed ID: 22595872
[TBL] [Abstract][Full Text] [Related]
8. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
[TBL] [Abstract][Full Text] [Related]
9. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
Haire B; Kaldor JM
Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
[TBL] [Abstract][Full Text] [Related]
10. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.
McMahon JM; Myers JE; Kurth AE; Cohen SE; Mannheimer SB; Simmons J; Pouget ER; Trabold N; Haberer JE
AIDS Patient Care STDS; 2014 Sep; 28(9):462-74. PubMed ID: 25045996
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Treatment-as-Prevention: A Cohort Study Analysis of Serodiscordant Couples in Rural Southwest China.
Tang Z; Lan G; Chen YQ; Zhu Q; Yang X; Shen Z; Chen Y; Zhang H; Kan W; Xing H; Ruan Y; Shao Y
Medicine (Baltimore); 2015 Jun; 94(24):e902. PubMed ID: 26091454
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria.
Folayan MO; Aliyu S; Oginni A; Ezechi O; Kolawole G; Ezeama N; Dadem N; Anenih J; Alagi M; Ekanem E; Afiadigwe E; Aguolu R; Oyebode T; Babalola-Jacobs A; Sagay A; Nweneka C; Kamofu H; Idoko J
PLoS One; 2022; 17(5):e0268011. PubMed ID: 35511948
[TBL] [Abstract][Full Text] [Related]
13. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy for prevention of HIV transmission: potential role for people who inject drugs in Central Asia.
McNairy ML; Deryabina A; Hoos D; El-Sadr WM
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S65-70. PubMed ID: 23880248
[TBL] [Abstract][Full Text] [Related]
15. A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemics.
Chaillon A; Hoenigl M; Mehta SR; Weibel N; Little SJ; Smith DM
Sci Rep; 2016 Jun; 6():28707. PubMed ID: 27337983
[TBL] [Abstract][Full Text] [Related]
16. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions.
Bazzi AR; Drainoni ML; Biancarelli DL; Hartman JJ; Mimiaga MJ; Mayer KH; Biello KB
BMC Public Health; 2019 Jan; 19(1):31. PubMed ID: 30621657
[TBL] [Abstract][Full Text] [Related]
18. The impact of the transmission dynamics of the HIV/AIDS epidemic on sexual behaviour: a new hypothesis to explain recent increases in risk taking-behaviour among men who have sex with men.
Boily MC; Godin G; Hogben M; Sherr L; Bastos FI
Med Hypotheses; 2005; 65(2):215-26. PubMed ID: 15922091
[TBL] [Abstract][Full Text] [Related]
19. Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.
Charurat ME; Emmanuel B; Akolo C; Keshinro B; Nowak RG; Kennedy S; Orazulike I; Ake J; Njoku O; Baral S; Blattner W;
J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2(Suppl 2):S114-23. PubMed ID: 25723975
[TBL] [Abstract][Full Text] [Related]
20. Preexposure prophylaxis for the prevention of HIV transmission to women.
Aaron E; Cohan D
AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
